Page last updated: 2024-08-21

ethyl pyruvate and Lupus Erythematosus, Systemic

ethyl pyruvate has been researched along with Lupus Erythematosus, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bao, Y; Dong, C; Fu, T; Ge, X; Gu, Z; Ji, J; Kong, X; Li, J; Lu, Z; Sha, X; Yang, J; Zhang, Z; Zhao, R; Zhu, W	1

Other Studies

1 other study(ies) available for ethyl pyruvate and Lupus Erythematosus, Systemic

Article	Year
Targeting HMGB1 by ethyl pyruvate ameliorates systemic lupus erythematosus and reverses the senescent phenotype of bone marrow-mesenchymal stem cells. Aging, 2019, 07-14, Volume: 11, Issue:13 Topics: Adolescent; Adult; Animals; Case-Control Studies; Cellular Microenvironment; Cellular Senescence; Drug Evaluation, Preclinical; Female; HMGB1 Protein; Humans; Lupus Erythematosus, Systemic; Mesenchymal Stem Cells; Mice; Middle Aged; Proteome; Pyruvates; Signal Transduction; Young Adult	2019

Article

Year

Targeting HMGB1 by ethyl pyruvate ameliorates systemic lupus erythematosus and reverses the senescent phenotype of bone marrow-mesenchymal stem cells.

Aging, 2019, 07-14, Volume: 11, Issue:13

Topics: Adolescent; Adult; Animals; Case-Control Studies; Cellular Microenvironment; Cellular Senescence; Drug Evaluation, Preclinical; Female; HMGB1 Protein; Humans; Lupus Erythematosus, Systemic; Mesenchymal Stem Cells; Mice; Middle Aged; Proteome; Pyruvates; Signal Transduction; Young Adult

2019